CD28 co-stimulation stabilizes the expression of the CD40 ligand on T cells

被引:49
|
作者
Johnson-Léger, C [1 ]
Christensen, J [1 ]
Klaus, GGB [1 ]
机构
[1] Natl Inst Med Res, Div Cellular Immunol, London NW7 1AA, England
关键词
CD40; ligand; T cell-B cell collaboration;
D O I
10.1093/intimm/10.8.1083
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The ligand for CD40 (CD40L) is a protein which is expressed on CD4 T cells following their activation: CD40-CD40L interactions are absolutely required for the induction of T cell-dependent antibody responses, yet little is known about the mechanisms whereby CD40L(+) primary T cells activate naive B cells, since the protein is only transiently expressed and is rapidly down-regulated following T cell-B cell contact. We show here, using a variety of assays, that co-stimulation of primary murine T cells via CD3 and CD28 stabilizes the expression of the CD40L protein. Firstly, T cells stimulated in this manner express higher levels of CD40L when activated in the presence of B cells, compared to CD3-activated T cells. Secondly, the CD40L expressed on CD28-co-stimulated T cells is more resistant to B cell-induced down-regulation. Finally, CD3/CD28-preactivated, rested T cells re-express higher levels of CD40L more rapidly following re-stimulation via CD3 than T cells preactivated via CD3 atone. CD3/CD28-preactivated T cells, but not CD3-activated cells, are competent to induce DNA synthesis in naive B cells, and this requires re-stimulation via CD3 and prolonged ligation of CD40, These data therefore reinforce the concept that naive T cells need to be activated initially by cognate interaction with B7-bearing antigen-presenting cells (such as dendritic cells), before becoming competent helper effector cells capable of driving B cells into proliferation via a CD40-dependent pathway.
引用
收藏
页码:1083 / 1091
页数:9
相关论文
共 50 条
  • [1] Targeting CD4+CD28- T cells by blocking CD28 co-stimulation
    Airo, Paolo
    Scarsi, Mirko
    TRENDS IN MOLECULAR MEDICINE, 2013, 19 (01) : 1 - 2
  • [2] Co-stimulation of CD28/CD40 signaling molecule potentiates CAR-T cell efficacy and stemness
    Khopanlert, Wannakorn
    Choochuen, Pongsakorn
    Maneechai, Kajornkiat
    Jangphattananont, Nawaphat
    Ung, Socheatraksmey
    Okuno, Shingo
    Steinberger, Peter
    Leitner, Judith
    Sangkhathat, Surasak
    Viboonjuntra, Pongtep
    Terakura, Seitaro
    Julamanee, Jakrawadee
    MOLECULAR THERAPY ONCOLOGY, 2024, 32 (03):
  • [3] Co-Stimulation of CD28/CD40 Signaling Molecule Potentiates CD19CAR-T Cell Functions and Stemness
    Khopanlert, Wannakorn
    Choochuen, Pongsakorn
    Jangphattananont, Nawaphat
    Maneechai, Kajornkiat
    Ung, Socheatraksmey
    Sangkhathat, Surasak
    Viboonjuntra, Pongtep
    Terakura, Seitaro
    Julamanee, Jakrawadee
    BLOOD, 2022, 140 : 7364 - 7365
  • [4] The roles of CD28 and CD40 ligand in T cell activation and tolerance
    Howland, KC
    Ausubel, LJ
    London, CA
    Abbas, AK
    JOURNAL OF IMMUNOLOGY, 2000, 164 (09): : 4465 - 4470
  • [5] CD40 LIGAND-TRANSDUCED CO-STIMULATION OF T-CELLS IN THE DEVELOPMENT OF HELPER FUNCTION
    VANESSEN, D
    KIKUTANI, H
    GRAY, D
    NATURE, 1995, 378 (6557) : 620 - 623
  • [6] The modulation of CD40 ligand signaling by transmembrane CD28 splice variant in human T cells
    Mikolajczak, SA
    Ma, BY
    Yoshida, T
    Yoshida, R
    Kelvin, DJ
    Ochi, A
    JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (07): : 1025 - 1031
  • [7] CD28/B7 CO-STIMULATION OF HUMAN T-CELLS
    LANIER, LL
    PHILLIPS, JH
    CAYABYAB, M
    AZUMA, M
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 97 - 97
  • [8] CD28 CO-STIMULATION OF T-CELL-MEDIATED CYTOTOXICITY
    AZUMA, M
    PHILLIPS, JH
    LANIER, LL
    INTERNATIONAL JOURNAL OF CANCER, 1992, : 33 - 35
  • [9] CD28 co-stimulation of T-cells requires PLCγ1 activity
    Conley, AA
    Bell, M
    Hedin, KE
    Irvin, BJ
    Abraham, RT
    McKean, DJ
    FASEB JOURNAL, 1999, 13 (05): : A946 - A946
  • [10] The complexities of T-cell co-stimulation: CD28 and beyond
    Sperling, AI
    Bluestone, JA
    IMMUNOLOGICAL REVIEWS, 1996, 153 : 155 - 182